Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Loxapine for Agitation in Schizophrenia
NCT00369577Phase 2Completed
- Sponsor
- Alexza Pharmaceuticals Inc
- Start
- Aug 2006
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of loxapine in schizophrenia, sponsored by Alexza Pharmaceuticals Inc. Started Aug 2006; status: completed.
02
Drugs
loxapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00369577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369577.